How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.

Fernando Magro Maria Manuela EstevinhoGaia CatalanoMarta PatitaBruno ArrojaPaula LagoIsadora Rosa Helena Tavares SousaPaula MinistroIrina MocanuAna VieiraJoana CastelaJoana MoleiroFernando MagroEugénia CancelaPaula SousaFrancisco PortelaLuís CorreiaPaula MoreiraMafalda SantiagoSandra DiasJoana AfonsoSilvio DaneseLaurent Peyrin BirouletCláudia Camila Diasnull null

Published in: United European gastroenterology journal (2023)

The combined evaluation of hemoglobin, CRP, and FC in at least one time point and their incorporation into risk matrices seems to be the optimal strategy for CD management, as data from additional visits did not meaningfully influence the predictions and may delay decision-making.

Keyphrases

end stage renal disease
decision making
ejection fraction
newly diagnosed
prognostic factors
electronic health record
peritoneal dialysis
big data
machine learning